This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) shed 1.88% to $129.58 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&amp;P 500 Index falling 1.24% to 7,408.50 and Dow Jones Industrial Average falling 1.07% to 49,526.17.
This was the stock's third consecutive day of losses.
Gilead Sciences Inc. closed 17.62% below its 52-week high of $157.29, which the company achieved on February 11th.
The stock underperformed when compared to some of its competitors Friday, as Johnson &amp; Johnson (JNJ) fell 1.77% to $226.71, Pfizer Inc. (PFE) fell 1.63% to $25.33, and Abbott Laboratories (ABT) fell 0.51% to $84.47.
Trading volume (6.6 M) eclipsed its 50-day average volume of 5.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-15-26 1635ET

GILD

Gilead Sciences Inc. (GILD) shares fell 1.88% to $129.58 on Friday, marking the third consecutive day of losses. The stock is now 17.62% below its 52-week high of $157.29. In comparison, competitors like Johnson & Johnson, Pfizer, and Abbott also experienced declines, but Gilead underperformed relative to them. Trading volume reached 6.6 million, surpassing the 50-day average of 5.9 million.

MarketWatch Automated

Gilead Sciences

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

Health Care Select Sector SPDR

Ark Genomic Revolution ETF

Invesco Nasdaq Biotechnology ETF

Invesco Biotechnology & Genome ETF

iShares US Pharma

First Trust NYSE Arca Biotech Index Fd

iShares Global Healthcare

Direxion S&P Biotech Bull 3X

VG Health

ALPS Medical Breakthrough

iShares Biotechnology ETF

VanEck Biotech ETF

Johnson & Johnson

Pfizer

Abbott Laboratories

S&P 500

Dow Jones Industrial Average

Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors